Long COVID is the patient-coined term for the disease entity whereby persistent symptoms
ensue in a significant proportion of those who have had COVID-19, whether asymptomatic …

Acute COVID-19 infection is followed by prolonged symptoms in approximately one in ten
cases: known as Long COVID. The disease affects~ 65 million individuals worldwide. Many …

Background Autoimmunity has been reported in patients with severe coronavirus disease
2019 (COVID-19). We investigated whether anti-nuclear/extractable-nuclear antibodies …

A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a
significant percentage of individuals within a few months after infection with SARS-CoV-2 …

In 2011, a syndrome entitled ASIA (Autoimmune/inflammatory Syndrome Induced by
Adjuvants; Shoenfeld's syndrome) was first described. ASIA aimed to organize under a …

Most patients with Post COVID Syndrome (PCS) present with a plethora of symptoms without
clear evidence of organ dysfunction. A subset of them fulfills diagnostic criteria of myalgic …

In the aftermath of the COVID-19 pandemic, we are witnessing an unprecedented wave of
post-infectious complications. Most prominently, millions of patients with Long-Covid …

Abstracts The coronavirus disease 2019 (COVID-19) affects infected patients even after the
acute phase and impairs their health and quality of life by causing a wide variety of …

G protein-coupled receptors (GPCR) are involved in various physiological and
pathophysiological processes. Functional autoantibodies targeting GPCRs have been …

The current epidemic of corona virus disease (COVID-19) has resulted in an immense
health burden that became the third leading cause of death and potentially contributed to a …